Atrys Health, S.A. (FRA:A2T)

Market Cap	195.84M -4.5%
Revenue (ttm)	144.31M +7.0%
Net Income	-100.30M
EPS	-1.32
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	2.265
Previous Close	2.440
Day's Range	2.265 - 2.440
52-Week Range	2.210 - 3.390
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through three segments: Diagnosis, Oncology, and Preventive Medicine. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; telediagnosis activities in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and...

• Industry: Medical Laboratories
• Founded: 2007
• Employees: 656
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A2T

Financial Performance

In 2025, Atrys Health's revenue was 144.31 million, an increase of 7.00% compared to the previous year's 134.88 million. Losses were -100.30 million, 215.7% more than in 2024.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error